peptides&elephants receives ProFIT funding for MHC Class I Peptide Pool launch
peptides&elephants has received funding through Brandenburg’s ProFIT Innovation Program, co-financed by the European Regional Development Fund (EFRE) and the State of Brandenburg.
The project “Market Launch: Establishment of a New Peptide Product Family – Introduction of Novel MHC Class I Peptide Pools” supports the development of a next-generation MHC Class I Peptide Pool product line. These peptide tools will advance immunological research by enabling more precise studies of T cell responses and antigen presentation.
With ProFIT support, peptides&elephants will:
- Launch innovative MHC Class I Peptide Pools
- Expand peptide synthesis and purification at the Hennigsdorf site
- Strengthen collaborations within Brandenburg’s biotech ecosystem
This project bridges peptide chemistry and translational immunology — helping to accelerate discoveries in infectious disease and cancer research.